Variables% or Mean ±SD | Survival n = 47 | Mortality n = 12 | P value |
---|---|---|---|
Clinical data | |||
Male | 35 (74.5) | 6 (50.0) | .267 |
Length of hospital stay | 25 ± 21 | 16 ± 10 | .052 |
Symptoms before echocardiography | 26 ± 37 | 16 ± 17 | .355 |
Duration of symptoms before diagnosis, median (IQR),days | 24.0 (12.0–42.0) | 29.0 (10.3–54.8) | .799 |
Time interval from emboli to diagnosis | 12 ± 10 | 11 ± 11 | .868 |
Time interval from cerebral emboli to diagnosis | 15 ± 13 | 12 ± 12 | .724 |
IE localization | |||
Native valve | 40 (85.1) | 9 (75.0) | .518 |
Prosthetic valve | 6 (12.8) | 2 (16.7) | .862 |
Community origin | 42 (89.4) | 5 (41.7) | P<0.001 |
Nosocomial origin | 2 (4.3) | 4 (33.3) | P<0.001 |
Comorbidities | |||
With predisposing cardiac disease | 29 (61.7) | 6 (50.0) | .457 |
Rheumatic heart disease | 8 (17.0) | 3 (25.0) | .752 |
Congenital heart disease | 9 (19.1) | 1 (8.3) | .482 |
Previous cardiac surgery | 10 (21.3) | 4 (33.3) | .475 |
Degenerative heart disease | 6 (12.8) | 0 | .466 |
Chronic pulmonary disease | 1 (2.1) | 1 (8.3) | .343 |
Cancer | 2 (4.3) | 0 | .690 |
Hemodialysis | 1 (2.1) | 3 (25.0) | .007 |
Liver cirrhosis | .713 | ||
Hypertension | 18 (38.3) | 7 (58.3) | .272 |
Diabetes | 7 (14.9) | 3 (25.0) | .565 |
Immunodepression | 0 | 4 (33.3) | P<0.001 |
Bad oral hygiene | 22 (46.8) | 7 (58.3) | .713 |
Symptoms and signs | |||
Anemia | 31 (66.0) | 7 (58.3) | .425 |
Fever | 44 (93.6) | 9 (75.0) | .046 |
Splenomegaly | 11 (23.4) | 2 (16.7) | .491 |
Hepatomegaly | 1 (2.1) | 1 (8.3) | .516 |
New or changing heart murmur | 39 (83.0) | 6 (50.0) | .021 |
Complications | |||
Heart failure | 25 (53.2) | 12 (100.0) | .106 |
Total emboli | 16 (34.0) | 7 (58.3) | .143 |
Emboli under treatment | 8 (17.0) | 4 (33.3) | .295 |
Intracranial infection | 1 (2.1) | 0 | .713 |
Cerebral emboli | 8 (17.0) | 6 (50.0) | .053 |
Cerebral hemorrhage | 1 (2.1) | 1 (8.3) | .404 |
Arrhythmia | 16 (34.0) | 7 (58.3) | .202 |
Renal insufficiency | 9 (19.1) | 9 (75.0) | .001 |
Hepatic insufficiency | 3 (6.4) | 3 (25.0) | .092 |
Pulmonary arterial hypertension | 15 (31.9) | 8 (66.7) | .037 |
Moderate or severe valve regurgitation | 10 (21.3) | 2 (16.7) | .570 |
Moderate or severe valve stenosis | 4 (8.5) | 1 (8.3) | .912 |
Annular abscess | 5 (10.6) | 2 (16.7) | .564 |
Pseudoaneurysm | 1 (2.1) | 1 (8.3) | .289 |
Valvular perforation | 10 (21.3) | 3 (25.0) | .781 |
Pitt score ≥ 4 | 1 (2.1) | 5 (41.7) | .001 |
Vegetation length | .062 | ||
≤10 mm | 25 (53.2) | 4 (33.3) | |
>10 mm<20 mm | 19 (40.4) | 5 (41.7) | |
≥20 mm ≤ 30 mm | 3 (6.4) | 1 (8.3) | |
>30 mm | 0 | 2 (16.7) | .039 |
Microbiology | .050 | ||
Streptococci | 12 (48.0) | 1 (16.7) | .268 |
Staphylococci | 8 (32.0) | 3 (50.0) | .679 |
Staphylococcus aureus | 0 | 2 (33.3) | .039 |
Enterococci | 1 (4.0) | 0 | |
Fungi | 0 | 1 (16.7) | |
Surgical treatment | 23 (48.9) | 1 (8.3) | .018 |